Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
JACC. Cardiovascular Interventions
|
February 5, 2021
Acute Kidney Injury Following In-Patient Lower Extremity Vascular Intervention: From the National Cardiovascular Data Registry
David M Safley, Adam C Salisbury, Thomas T Tsai, et al.
Clinical Cardiology
|
October 3, 2013
Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease
Matthew A Cavender, Andrew N Rassi, Gregg C Fonarow, et al.
The American Journal of Cardiology
|
September 18, 2018
Meta-Analysis Comparing Complete or Culprit Only Revascularization in Patients With Multivessel Disease Presenting With Cardiogenic Shock
Maurizio Bertaina, Ilenia Ferraro, Pierlugi Omedè, et al.
JAMA Network Open
|
April 24, 2023
Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
Christopher P Cannon, Joseph M Kim, Jane J Lee, et al.
Circulation. Cardiovascular Interventions
|
August 13, 2017
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIX
Matthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
Circulation
|
August 3, 2016
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)
Matthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
JAMA
|
November 20, 2013
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial
Stephen J Nicholls, John J P Kastelein, Gregory G Schwartz, et al.
Circulation. Cardiovascular Interventions
|
December 17, 2021
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
Matthew A Cavender, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology
|
May 6, 2021
Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention
Yulanka S Castro-Dominguez, Yongfei Wang, Karl E Minges, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 30, 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
JACC. Cardiovascular Interventions
|
February 5, 2021
Acute Kidney Injury Following In-Patient Lower Extremity Vascular Intervention: From the National Cardiovascular Data Registry
David M Safley, Adam C Salisbury, Thomas T Tsai, et al.
Clinical Cardiology
|
October 3, 2013
Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease
Matthew A Cavender, Andrew N Rassi, Gregg C Fonarow, et al.
The American Journal of Cardiology
|
September 18, 2018
Meta-Analysis Comparing Complete or Culprit Only Revascularization in Patients With Multivessel Disease Presenting With Cardiogenic Shock
Maurizio Bertaina, Ilenia Ferraro, Pierlugi Omedè, et al.
JAMA Network Open
|
April 24, 2023
Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
Christopher P Cannon, Joseph M Kim, Jane J Lee, et al.
Circulation. Cardiovascular Interventions
|
August 13, 2017
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIX
Matthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
Circulation
|
August 3, 2016
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)
Matthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
JAMA
|
November 20, 2013
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial
Stephen J Nicholls, John J P Kastelein, Gregory G Schwartz, et al.
Circulation. Cardiovascular Interventions
|
December 17, 2021
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
Matthew A Cavender, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology
|
May 6, 2021
Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention
Yulanka S Castro-Dominguez, Yongfei Wang, Karl E Minges, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 30, 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, et al.
Page
of 9